Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aflibercept vs Ranibizumab in Diabetic Macular Edema
NCT04087746Phase 4Completed
- Sponsor
- Minia University
- Start
- Jan 2017
- Primary completion
- Jan 2019
- Modality
- Antibody Fragments, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of aflibercept, ranibizumab in diabetic macular edema (DME), sponsored by Minia University. Started Jan 2017; status: completed.
02
Drugs
afliberceptranibizumab
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT04087746.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04087746.